Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Papillomavirus Infections 2Leiomyoma 2Inflammation 2Frailty 2Uterine Cervical Dysplasia 1Squamous Intraepithelial Lesions 1Radiodermatitis 1Liver Neoplasms 1Liver Cirrhosis 1Fibrosis 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Atypical Squamous Cells of the Cervix 1

Interventions

Human Papillomavirus DNA Tests 4Colposcopy 4Watchful Waiting 3Biopsy 3Acetic Acid 3Transurethral Resection of Prostate 2Restraint, Physical 2Conization 2Blood Specimen Collection 2pembrolizumab 1human papillomavirus vaccine, L1 type 16, 18 1fludarabine phosphate 1fludarabine 1epigallocatechin gallate 1artesunic acid 1artemisinin 1aldesleukin 1Vaccines 1Ultrasonography, Doppler 1Transdermal Patch 1Respiratory Function Tests 1Prochlorperazine 1Pregnancy Tests 1Positron-Emission Tomography 1Papanicolaou Test 1Ondansetron 1O(6)-codeine methyl ether 1Nicotine Replacement Therapy 1Mutagenesis, Insertional 1Molecular Diagnostic Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Cervical Dysplasia × epigallocatechin gallate × 1 year × Clear all
NCT07572396 2026-05-14

Phase II Study of Dysplasixâ„¢ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

Amplexd Therapeutics, Inc.

Phase 2 Recruiting
45 enrolled
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

Data powered by HemOnc (CC BY 4.0) Colophon âš¡